Abstract:Many therapies in cardiovascular medicine are aimed primarily at reducing mortality or serious morbidity. A therapy that “only” improves quality of life may seem less valuable in the light of the great success of many treatments in improving survival. Nevertheless, patients greatly value treatments that improve quality of life, reduce symptoms, and improve functional capability. These outcomes are directly and immediately evident to the patient, in contrast to the imperceptible reduction of risk. The benefit of radiofrequency ablation (RFA) is chiefly achieved by reducing the frequency of symptomatic arrhythmias, which in turn may improve patient well-being and quality of life. Successful RFA reduces the frequency of paroxysmal supraventricular tachycardia, atrial flutter, and atrial fibrillation in properly selected patients. Elimination of paroxysmal symptoms can improve the patients’ quality of life in three ways: first, by elimination of the actual episodes of symptomatic arrhythmia; second, by reducing patients’ anxiety and activity restrictions due to the ever-present possibility of arrhythmia recurrence; and third, by reducing the use of antiarrhythmic medications and their associated adverse effects.1 RFA has also been applied to chronic, persistent arrhythmias such as poorly tolerated atrial fibrillation. In these individuals, quality of life is persistently reduced by the ongoing arrhythmia, and RFA may improve overall quality of life and functional capacity. RFA of the atrioventricular node and subsequent pacemaker implantation to treat refractory atrial fibrillation has been shown in randomized trials to reduce symptoms and improve quality of life.2–4 Frequent premature ventricular beats may also cause severe and disabling symptoms. Patients with a focal origin for incessant premature ventricular beats are candidates for RFA to reduce the frequency of arrhythmia. Huang and coworkers5 show that patients who had extremely

Study on the degradation of zearalenone by Micrococcus luteus.

Toxicity, biodegradation, and nutritional intervention mechanism of zearalenone

Exploration on the Enhancement of Detoxification Ability of Zearalenone and Its Degradation Products of Aspergillus niger FS10 under Directional Stress of Zearalenone

ISOLATION,IDENTIFICATION AND DEGRADATION CHARACTERISTICS OF A HERBICIDE ZJ0273-DEGRADING STRAIN CY

[Screening of zearalenone-degrading bacteria and analysis of degradation conditions]

Study on Kinetics of Microcystin-LR Degradation by Ozonation

An overview of chemical, physical and biological methods for zearalenone elimination: Recent advances and future prospective

Improvement in Quality of Life after Radiofrequency Ablation

Detoxification of Zearalenone by Three Strains of Lactobacillus Plantarum from Fermented Food in Vitro

Degradation Characteristics and Applications ofAmycolatopsis sp.M3-1 for ZJ0273

Effective degradation of zearalenone by dye-decolorizing peroxidases from Pleurotus ostreatus and its metabolic pathway and toxicity analysis

Mutation, food-grade expression, and characterization of a lactonase for zearalenone degradation

Screening of Pig-Derived Zearalenone-Degrading Bacteria through the Zearalenone Challenge Model, and Their Degradation Characteristics

Novel lactobacillus consortium for effective zearalenone adsorption and biodegradation

Kinetics, Thermodynamics and Mechanism of Enzymatic Degradation of Zearalenone in Degummed Corn Oil

Characteristics of a Novel Zearalenone Lactone Hydrolase ZHRnZ and Its Thermostability Modification

Isolation and Mechanistic Characterization of a Novel Zearalenone-Degrading Enzyme

Review on microbial degradation of zearalenone and aflatoxins

Enhancing the thermal stability and activity of zearalenone lactone hydrolase to promote zearalenone degradation via semi-rational design

Application of food-grade microorganism in degradation of zearalenone

New Hydrolase from Aeromicrobium sp. HA for the Biodegradation of Zearalenone: Identification, Mechanism, and Application